key: cord-0931537-ma4tx5ft
authors: Rana, Muhammad Suleman
title: Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan
date: 2020-11-13
journal: J Infect
DOI: 10.1016/j.jinf.2020.11.013
sha: 59b7f2b241f3bb8b653ac87df98177ab7b70ecb6
doc_id: 931537
cord_uid: ma4tx5ft

nan

The epidemic of SARS-CoV-2 emerged in Wuhan, China become a serious public health threat and has been spread to 213 countries of the world. The World Health Organization has been declared this epidemic as a public Health Emergency of International concern on 30 January 2020. As of 6 September 2020, over 49 million confirmed cases and over 12 million deaths have been reported across the globe [2].

First case of COVID-19 in Pakistan, was detected on February 26, 2020; the toll then reached at 3,40,251 confirmed cases including 6,923 deaths as of September 6, 2020 [2].

It is important to know the difference among the demographic, clinical and laboratory characteristics of recovered and deceased COVID-19 patients for the proper case management, which will be helpful to reduce the rate of mortality.

For this retrospective single center study, we includes 100 critical COVID-19 confirmed patients admitted to the intensive care unit of a tertiary care hospital in Islamabad Pakistan, from June 12 to July 4, 2020. Laboratory confirmation of SARS-CoV-2 was done at the department of Virology, National Institute of Health (NIH) Islamabad through real-time reverse-transcriptase polymerase chain reaction (PCR) assay using nasopharyngeal swab specimens. We obtained demographic features, clinical symptoms, laboratory tests and outcome data from patient's electronic medical records.

Clinical outcomes were follow up to 17 July 2020. The SPSS Statistics 23.0 software (SPSS Inc., Chicago, IL, USA) was used to perform statistical analysis of the data. A value of P < 0.05 was considered to be statistically significant. The study was approved by the internal review board of NIH and written informed consent was obtained from the patients enrolled for the study.

A total of 100 confirmed COVID-19 patients were enrolled in the study, including 82 who were fully recovered and 18 who died in the hospital. The mean age of recovered patients was 45 years, while that of the deceased group was 60 years (p<0.003). In the recovered group 78% were male and 29.9% were female whereas in deceased group 61% were male and 38.9% were female. There was no any significant difference found in the socioeconomic status of both group. Among the recovered/deceased group majority of the patients exhibited fever (95/100%), fatigue (74/94%), cough (57/72%), loss of taste and smell (62/83%) breathing difficulties (47/88%), headache (54/77%), chest pain (12/77%) and diarrhea (28/61%) respectively. The shortness of breath and chest pain were significantly different between the both group p<0.001.

Most of the laboratory variables, including white blood cell (WBC) count, neutrophil, significantly different between the recovered and deceased group (p<0.001). High percentage (44%) of deceased patients were belong to the blood group ABfollowed 22% belong to AB + whereas the high percentage (39%) in the recovered group belong to blood group Afollowed by 20% belong to O + blood group. Three common comorbidities such as diabetes, sepsis and pulmonary diseases were significantly different between the both group (p<0.001). The mean duration from the onset to recovery was 18 days and for death it was 26 days and there was a significant difference between the both groups (p<0.001). Up to 17 July 2020, 82(82%) patients had been fully recovered and discharged from the hospital while 18 (18%) patients had died in the hospital. Detail of demographic, clinical and laboratory features is summaries in the This descriptive study presents the current status of COVID-19 in Pakistan along with the major differences in of clinical and laboratory characteristics between the patients who recovered and those who died from it.

In the present study the mean age of COVID-19 infected deceased patients was significantly older than that of recovered patients and similar findings has been reported in the previous study [3] . We observed a greater number of male than female in the 100 cases infected by SARS-CoV-2 as already reported during SARS-CoV epidemics [4] .

Clinical manifestations documented in our study were fever, fatigue, cough, rash, runny nose, sore throat, breathing difficulties, chest pain, loss of smell and taste, vomiting and diarrhea and such type of clinical information have reported in the recent study [5] . In term of laboratory tests lymphocytopenia, thrombocytopenia, low WBC count, reduced hemoglobin and elevated coagulation markers were observed in most of the COVID-19 infected patients. The elevated level of biochemical markers, cardiac enzymes, LDH, glucose, CRP and decrease level of electrolytes were noted in study patients coinciding with the results of previous study [6] . Majority (39%) of COVID-19 patients who recovered were belong to the blood group Awhereas the 44% of deceased group belong to ABblood group however the blood group related impact of COVID-19 have not been reported previously. Results of present study suggest that SARS-CoV-2 more likely infect the older men with chronic comorbidities such as diabetes, sepsis, pulmonary diseases and with AB blood group may results in severe and even fatal outcome. The median time from the disease onset to recovery and deaths was 18 and 26 days respectively and similar findings have been reported from China [7] . Older age, male sex, comorbidities and AB blood group are believed to be the major risk factor for critical illness and deaths from COVID-19 infection.

This study has several limitations such as small number of cases, single center study, lack of radiological findings and treatment details. The preliminary data derived from the present study permit an early assessment of demographic, clinical and laboratory features of recovered and deceased COVID-19 patients in Islamabad Pakistan.

The actual picture of recovered and deceased COVID-19 patients in Pakistan warranted further investigation at the country level.

All contributing authors stated that there are no conflicts of interest to declare Funding: 

Clinical features of critically ill patients with confirmed COVID-19

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China

Clinical characteristics of coronavirus disease 2019 in China

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine